A Study of CYP-001 in Combination with Corticosteroids in Adults with High-risk AGvHD
Phase 2
Recruiting
- Conditions
- Graft Versus Host Disease, Acute
- Interventions
- Drug: CorticosteroidsBiological: Placebo
- First Posted Date
- 2022-12-09
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 60
- Registration Number
- NCT05643638
- Locations
- 🇫🇷
Hôpital Universitaire Pitié-Salpêtrière, Paris, France
🇮🇹Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy
🇮🇹ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
Safety, Tolerability and Efficacy of CYP-006TK in Adults with Diabetic Foot Ulcers
Phase 1
Completed
- Conditions
- Cutaneous UlcerDiabetic Foot Ulcer
- Interventions
- Combination Product: CYP-006TK
- First Posted Date
- 2021-12-21
- Last Posted Date
- 2025-01-24
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 30
- Registration Number
- NCT05165628
- Locations
- 🇦🇺
Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
🇦🇺Fiona Stanley Hospital, Perth, Western Australia, Australia
🇦🇺Royal Perth Hospital, Perth, Western Australia, Australia
The MEseNchymal coviD-19 Trial: MSCs in Adults With Respiratory Failure Due to COVID-19 or Another Underlying Cause
Phase 1
Completed
- Conditions
- Covid19Acute Respiratory Distress Syndrome
- Interventions
- Biological: CYP-001
- First Posted Date
- 2020-09-03
- Last Posted Date
- 2023-09-01
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 14
- Registration Number
- NCT04537351
- Locations
- 🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺Westmead Hospital, Westmead, New South Wales, Australia
🇦🇺Footscray Hospital, Footscray, Victoria, Australia
A Study of CYP-001 for the Treatment of Steroid-Resistant Acute Graft Versus Host Disease
Phase 1
Completed
- Conditions
- Graft vs Host Disease
- Interventions
- Biological: Mesenchymoangioblast-derived mesenchymal stem cells
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2020-08-11
- Lead Sponsor
- Cynata Therapeutics Limited
- Target Recruit Count
- 16
- Registration Number
- NCT02923375
- Locations
- 🇬🇧
NHS Foundation Trust, Nottingham, United Kingdom
🇬🇧NHS Trust, Leeds, United Kingdom
🇦🇺Sydney Local Health District, Sydney, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath